(Q52585778)

4 May 2018

title

NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. (English)

1 reference

4 May 2018

author name string

W Qi

1

1 reference

4 May 2018

K Shakalya

2

1 reference

4 May 2018

A Stejskal

3

1 reference

4 May 2018

A Goldman

4

1 reference

4 May 2018

S Beeck

5

1 reference

4 May 2018

L Cooke

6

1 reference

4 May 2018

D Mahadevan

7

1 reference

4 May 2018

language of work or name

English

0 references

publication date

17 March 2008

1 reference

4 May 2018

published in

Oncogene

1 reference

4 May 2018

volume

27

1 reference

4 May 2018

issue

30

1 reference

4 May 2018

page(s)

4210-4220

1 reference

4 May 2018

Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleolar protein B23.1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin is required for DNA integrity and p19Arf protein stability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin regulates the stability and transcriptional activity of p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

31 March 2020

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Sedimentation analyses of the salt- and divalent metal ion-induced oligomerization of nucleolar protein B23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Mapping the functional domains of nucleolar protein B23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

C23 interacts with B23, a putative nucleolar-localization-signal-binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin and human cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis following Treatment with Imatinib Mesylate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin sets a threshold for p53 response to UV radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

The structure and function of Xenopus NO38-core, a histone chaperone in the nucleolus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin: a versatile molecule associated with hematological malignancies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

The role of nucleophosmin in centrosome duplication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Regulation of the p53 tumor suppressor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Reduced numatrin/B23/nucleophosmin labeling in apoptotic Jurkat T-lymphoblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Induction of Immune Responses to Ovarian Tumor Antigens by Multiparity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.54

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.54

1 reference

4 May 2018

1 reference

4 May 2018